spacer
spacer

PDBsum entry 1h0d

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Immune system/hydrolase PDB id
1h0d
Contents
Protein chains
216 a.a. *
223 a.a. *
123 a.a. *
Ligands
SO4 ×8
GOL ×6
Waters ×327
* Residue conservation analysis

References listed in PDB file
Key reference
Title The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody.
Authors G.B.Chavali, A.C.Papageorgiou, K.A.Olson, J.W.Fett, G.Hu, R.Shapiro, K.R.Acharya.
Ref. Structure, 2003, 11, 875-885. [DOI no: 10.1016/S0969-2126(03)00131-X]
PubMed id 12842050
Abstract
The murine monoclonal antibody 26-2F neutralizes the angiogenic and ribonucleolytic activities of human angiogenin (ANG) and is highly effective in preventing the establishment and metastatic dissemination of human tumors in athymic mice. Here we report a 2.0 A resolution crystal structure for the complex of ANG with the Fab fragment of 26-2F that reveals the detailed interactions between ANG and the complementarity-determining regions (CDRs) of the antibody. Surprisingly, Fab binding induces a dramatic conformational change in the cell binding region of ANG at the opposite end of the molecule from the combining site; crosslinking experiments indicate that this rearrangement also occurs in solution. The ANG-Fab complex structure should be invaluable for designing maximally humanized versions of 26-2F for potential clinical use.
Figure 1.
Figure 1. Structure of the Complex Formed between Human ANG and Fab 26-2FThe L and H chains of the Fab molecule are in magenta and blue, respectively, except for their CDRs (L1-L3 and H1-H3), which are in gold and cyan, respectively. ANG, green. Sulfate ions (yellow bonds) and glycerol molecules (green bonds) are also shown. The figure was generated with MOLSCRIPT (Kraulis, 1991).
The above figure is reprinted by permission from Cell Press: Structure (2003, 11, 875-885) copyright 2003.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer